Laparotomy Conversion Rates Comparison

## Laparotomy Conversion Rates: Robotic-Assisted vs. Conventional Laparoscopic Hysterectomy for Endometrial Cancer Based on the retrieved evidence, robotic-assisted laparoscopy (RA) is associated with a **significantly lower rate of conversion to laparotomy** compared to conventional laparoscopy (LSC) in the surgical management of endometrial cancer. ### Quantitative Comparison | Outcome | Robotic-Assisted (RA) | Conventional Laparoscopy (LSC) | P-value | Source | |---------|----------------------|-------------------------------|---------|--------| | Conversion to laparotomy rate | 3.5% (26/748) | 9.8% (15/153) | **0.02** | [1] | In a retrospective study of 901 patients with clinically uterine-confined high-grade endometrial adenocarcinoma, the conversion rate was **3.5%** in the RA group versus **9.8%** in the LSC group, a statistically significant difference (p=0.02) [1]. ### Supporting Evidence from Guidelines The British Gynaecological Cancer Society (BGCS) guidelines note that a meta-analysis reported a **significant difference** in conversion to laparotomy rates favoring robotic-assisted surgery, although one small RCT (n=99) showed a numerical but non-significant difference (0 cases for RA vs 5 cases for LSC) [2]. The BGCS assigns this evidence a **Grade B** recommendation, stating that robotic-assisted surgery appears non-inferior to laparoscopy and laparotomy for endometrial cancer treatment [2]. ### Clinical Context The reduced conversion rate with RA is clinically meaningful because conversion to laparotomy is associated with increased operative time, blood loss, and prolonged hospital stay, which ultimately impact patient-reported outcomes [1]. The study analyzed patients by intention-to-treat, meaning those who converted were analyzed in their originally assigned surgical group [1]. ### Study Limitations - The primary evidence [1] is **retrospective** and non-randomized; surgical approach was determined by surgeon preference, introducing potential selection bias - The RA group had a significantly higher median BMI (29.8 vs 28.7 kg/m², p=0.02) and younger median age (65.0 vs 66.7 years, p=0.04), suggesting RA may have been preferentially used in more complex patients [1] - Long-term oncological outcome data remain limited, as noted by the BGCS guidelines [2] --- **Disclaimer**: This analysis is based on retrieved literature and is intended for clinical reference. Individual surgical decisions should consider patient-specific factors, surgeon expertise, and institutional resources.